In agreement with the notion that TSPYL2 is a negative cell cycle regulator, TSPYL2 is silenced in glioma tissues, malignant lung tissues and certain lung tumor cell lines [14], [15]. This evidence concerns the gene TSPYL2 and central nervous system cancer.